Etoposide (VP-16-213).
D000328:Adult; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects; D002648:Child; D004064:Digestive System / Q000187:drug effects; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D051381:Rats
D005047:Etoposide; D011034:Podophyllotoxin